PROM1 and colonic neoplasm: Furthermore, DLD-1 colon cancer cells that survived multiple rounds of 5-ALA-PDT exhibited increased expression of the stem cell marker CD133, indicating that 5-ALA-PDT was ineffective in killing these specific cells.